Patent details

EP2229936 Title: Nanonized testosterone formulations for improved bioavailability

Basic Information

Publication number:
EP2229936
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP090033705
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Nanonized testosterone formulations for improved bioavailability
French Title of Invention:
Formules de testostérone de taille nano pour une meilleure biodisponibilité
German Title of Invention:
Nanonisierte Testosteronformulierungen für verbesserte Bioverfügbarkeit
SPC Number:

Dates

Filing date:
09/03/2009
Grant date:
06/05/2015
EP Publication Date:
06/05/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/09/2010
EP B1 Publication Date:
06/05/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/03/2016
Expiration date:
09/03/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/03/2009
 
 

Name:
PharmaSol GmbH
Address:
Blohmstrasse 66a, 12307 Berlin, Germany (DE)

Inventor

1

Name:
Keck Cornelia
Address:
Germany (DE)

2

Name:
Muchow Marc
Address:
Germany (DE)

Classification

Main IPC Class:
A61K 9/14;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages